You are viewing the comprehensive archive for articles tagged with "pharmaceuticals". Our editorial team provides essential coverage, in-depth analysis, and real-time market data across all critical topics impacting the global economy. This section compiles the most relevant news, research, and expert commentary to help you navigate the trends and forces shaping the financial world. Stay informed with MarketSpeaker to ensure your knowledge is current and comprehensive.
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
Novartis has agreed to acquire immunology biotech Excellergy for $2 billion, marking its second major deal in a week. The move strengthens its pipeline in next-generation allergy treatments.